Cargando…

The role of BCL11B in hematological malignancy

The B-cell leukemia/lymphoma 11B (BCL11B) gene is a member of the BCL family which plays a crucial role in the development, proliferation, differentiation and subsequent survival of T cells. BCL11B gene alterations are related to malignant T cell transformation that occurs in hematological malignanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xin, Du, Xin, Li, Yangqiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514087/ https://www.ncbi.nlm.nih.gov/pubmed/23211040 http://dx.doi.org/10.1186/2162-3619-1-22

Ejemplares similares

Gene expression profiles in BCL11B-siRNA treated malignant T cells
por: Huang, Xin, et al.
Publicado: (2011)

Roles and Regulation of BCL-xL in Hematological Malignancies
por: Morales-Martínez, Mario, et al.
Publicado: (2022)

The roles of stem cell memory T cells in hematological malignancies
por: Xu, Ling, et al.
Publicado: (2015)

Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia
por: Huang, Xin, et al.
Publicado: (2010)

BCL-2 as therapeutic target for hematological malignancies
por: Perini, Guilherme Fleury, et al.
Publicado: (2018)

Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome
por: Huang, Xin, et al.
Publicado: (2021)

T cell senescence and CAR-T cell exhaustion in hematological malignancies
por: Kasakovski, Dimitri, et al.
Publicado: (2018)

The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies
por: Shi, Li, et al.
Publicado: (2013)

Alternative splicing of BCL-X and implications for treating hematological malignancies
por: Chen, Wanling, et al.
Publicado: (2021)

Role of Wnt canonical pathway in hematological malignancies
por: GE, Xueling, et al.
Publicado: (2010)

The importance of genomic predictors for clinical outcome of hematological malignancies
por: Chen, Cunte, et al.
Publicado: (2021)

Combination strategies to overcome resistance to the BCL2 inhibitor venetoclax in hematologic malignancies
por: Yue, XiaoYan, et al.
Publicado: (2020)

Role of the transcription factor Bcl11b in development and lymphomagenesis
por: KOMINAMI, Ryo
Publicado: (2012)

Inhibition of BCL11B induces downregulation of PTK7 and results in growth retardation and apoptosis in T-cell acute lymphoblastic leukemia
por: Li, Kehan, et al.
Publicado: (2021)

Roles of circRNAs in hematological malignancies
por: Deng, Fahua, et al.
Publicado: (2022)

Combination of BCL11A siRNA with vincristine increases the apoptosis of SUDHL6 cells
por: He, Dongmei, et al.
Publicado: (2014)

Role of circular RNA in hematological malignancies
por: Mei, Mei, et al.
Publicado: (2019)

T-cell immunodeficiency and reconstruction based on TCR rearrangement analysis in hematological malignancy: update from 2011 ASH annual meeting
por: Li, Yangqiu
Publicado: (2012)

Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies
por: Testa, Ugo, et al.
Publicado: (2022)

NF-κB in Hematological Malignancies
por: Imbert, Véronique, et al.
Publicado: (2017)

Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting
por: Tan, Jiaxiong, et al.
Publicado: (2023)

The role of A20 in the pathogenesis of lymphocytic malignancy
por: Zhang, Fan, et al.
Publicado: (2012)

The functions and clinical significance of circRNAs in hematological malignancies
por: Zhou, Xiangxiang, et al.
Publicado: (2020)

Expanding role of lenalidomide in hematologic malignancies
por: Ghosh, Nilanjan, et al.
Publicado: (2015)

Role of CD47 in Hematological Malignancies
por: Eladl, Entsar, et al.
Publicado: (2020)

Update on the role of copanlisib in hematologic malignancies
por: Le, Thuy, et al.
Publicado: (2021)

Role of Notch Receptors in Hematologic Malignancies
por: Gragnani, Laura, et al.
Publicado: (2020)

BCL11B Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic Leukemia
por: Chen, Cunte, et al.
Publicado: (2023)

Role of IL-9 and STATs in hematological malignancies (Review)
por: CHEN, NA, et al.
Publicado: (2014)

Role of Extracellular Vesicles in Hematological Malignancies
por: Raimondo, Stefania, et al.
Publicado: (2015)

Targeting CD22 for B-cell hematologic malignancies
por: Xu, Jia, et al.
Publicado: (2023)

The Role of Deubiquitinating Enzymes in Hematopoiesis and Hematological Malignancies
por: Sarodaya, Neha, et al.
Publicado: (2020)

Role of Circulating Tumor DNA in Hematological Malignancy
por: Ogawa, Miho, et al.
Publicado: (2021)

Function of Deptor and its roles in hematological malignancies
por: Morales-Martinez, Mario, et al.
Publicado: (2021)

The Role of Tumor-Associated Macrophages in Hematologic Malignancies
por: Cencini, Emanuele, et al.
Publicado: (2021)

The Role of RNA-Binding Proteins in Hematological Malignancies
por: Aguilar-Garrido, Pedro, et al.
Publicado: (2022)

Advancements on the Multifaceted Roles of Sphingolipids in Hematological Malignancies
por: Raza, Yasharah, et al.
Publicado: (2022)

Metabolic Reprogramming in Hematologic Malignancies: Advances and Clinical Perspectives
por: Yu, Zhuoya, et al.
Publicado: (2022)

SF3B1 Mutations in Hematological Malignancies
por: Cilloni, Daniela, et al.
Publicado: (2022)

Molecular functions of metallothionein and its role in hematological malignancies
por: Takahashi, Shinichiro
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_b50mj3navl3bu6t3q8enm9p2i5